The LIFX transaction spreads the company's business risk, which is terrific.
This working capital financing arrangement is a good support facility for LIFX.
I think this B2C play could drive exponential company growth.
However, I wouldn't want to see the OHM side of the business rest on its laurels.
A lot of shareholder funds have gone into developing OHM.
I'm hoping the March 4C shows substantial sales.
If not, I would like to understand how BUD is going to drive OHM growth.
It'd be good for the 4C to detail the business strategy going forward.
Yak.